Follow The Cigna Group to never miss an important update.
Guggenheim kept its buy rating and raised its target from $338 to $361. This move comes after the company showed it can grow its pharmacy and specialty drug business even while the broader insurance industry faces rising costs for medical care.
The higher target suggests analysts see more room for the stock to rise as the company shifts toward its higher-margin health services division, Evernorth. This part of the business earns fees for managing prescriptions rather than just taking on the risk of paying for medical claims.
Source: Guggenheim
The company reported adjusted profit of $7.78 per share, which was better than the $7.60 analysts expected. Total revenue rose 7 percent to about 71.7 billion dollars. This growth was led by the health services and pharmacy-benefit units, which manage drug plans for employers and insurers.
Management also raised its profit forecast for the full year to at least $30.45 per share. This is a positive sign because it shows the company is successfully navigating a period where many health insurers are struggling with higher-than-expected costs for medical procedures. By relying more on its pharmacy services, the business is becoming less sensitive to those unpredictable medical swings.
See the full quarter, and how our tracked metrics did
Source: 8-K filing
The healthcare division is using new AI and predictive analytics to find patients who need help managing complex or chronic conditions earlier. The company expects these tools to save customers about 200 million dollars in medical expenses over the next three years.
For a long-term owner, this is a clear example of using technology to improve the medical care ratio, which is the percentage of premiums spent on actual medical care. By intervening early, the company can help patients stay healthier and avoid expensive hospital stays, which protects profit margins in the insurance arm.
Source: Reuters
The company will pay its regular quarterly dividend on September 23 to shareholders who own the stock by September 8. This payment is part of the company's plan to return cash to its owners. While this is a routine announcement, it confirms the company's steady cash generation. A reliable dividend is often a sign of a mature business that generates more cash than it needs to fund its daily operations and growth.
Source: PRNewsWire
Management consistently sets a beatable bar, delivering seven beats in the last eight quarters. This pattern shows a team that has a firm grip on its costs and predictable growth.
| Expectation | |
|---|---|
| EPS | $7.49 |
| Revenue | $72.65B |
Follow The Cigna Group to get the latest and most important updates.
Follow CI